Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Clinical and angiographic factors predicting fractional flow reserve and explaining the visual-functional mismatch in patients with intermediate coronary artery stenosis.

Watanabe H, Onishi K, Kakehi K, Takase T, Yamaji K, Ueno M, Kobuke K, Miyazaki S, Iwanaga Y.

Coron Artery Dis. 2019 Oct 10. doi: 10.1097/MCA.0000000000000817. [Epub ahead of print]

PMID:
31609758
2.

Elevated cerebrospinal fluid levels of total protein in patients with secondary central nervous system vasculitis and giant cell arteritis.

Abe Y, Harada M, Tada K, Yamaji K, Tamura N.

Mod Rheumatol. 2019 Oct 24:1-6. doi: 10.1080/14397595.2019.1679974. [Epub ahead of print]

PMID:
31599690
3.

Impact of Reduced-Dose Prasugrel vs. Standard-Dose Clopidogrel on In-Hospital Outcomes of Percutaneous Coronary Intervention in 62,737 Patients with Acute Coronary Syndromes: A Nationwide Registry Study in Japan.

Akita K, Inohara T, Yamaji K, Kohsaka S, Numasawa Y, Ishii H, Amano T, Kadota K, Nakamura M, Maekawa Y.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 8. pii: pvz056. doi: 10.1093/ehjcvp/pvz056. [Epub ahead of print]

PMID:
31593213
4.

Diagnosis of giant cell arteritis by head-contrast three-dimensional computed tomography angiography: two case reports.

Kawamoto T, Ogasawara M, Nakano S, Matsuki Muramoto Y, Matsushita M, Yamanaka K, Yamaji K, Tamura N.

J Med Case Rep. 2019 Sep 11;13(1):285. doi: 10.1186/s13256-019-2199-0.

5.

Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.

Abe Y, Kusaoi M, Tada K, Yamaji K, Tamura N.

Rheumatology (Oxford). 2019 Aug 27. pii: kez357. doi: 10.1093/rheumatology/kez357. [Epub ahead of print]

PMID:
31504956
6.

Clinical impact of improvement in the ankle-brachial index after endovascular therapy for peripheral arterial disease.

Katsuki T, Yamaji K, Tomoi Y, Hiramori S, Soga Y, Ando K.

Heart Vessels. 2019 Aug 23. doi: 10.1007/s00380-019-01485-z. [Epub ahead of print]

PMID:
31444562
7.

Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease.

Matsumura-Nakano Y, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Yamaji K, Shizuta S, Sakata R, Hanyu M, Shimamoto M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ J. 2019 Sep 25;83(10):2061-2069. doi: 10.1253/circj.CJ-19-0440. Epub 2019 Aug 22.

8.

Immunosuppressive therapy to reduce mitral regurgitation in Libman-Sacks endocarditis: a case report.

Ishizu K, Isotani A, Yamaji K, Ando K.

Eur Heart J Case Rep. 2019 Sep 1;3(3). pii: ytz133. doi: 10.1093/ehjcr/ytz133.

9.

First Experience of Robotic-assisted Percutaneous Coronary Intervention in Japan.

Kagiyama K, Ueno T, Mitsutake Y, Yamaji K, Ishimatsu T, Sasaki KI, Fukumoto Y.

Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3272-19. [Epub ahead of print]

10.

Picture superiority effect as one of the potential advantages of musculoskeletal ultrasound complementation for verbal explanation.

Matsuki-Muramoto Y, Ogasawara M, Kawamoto T, Yamaji K, Tamura N.

Mod Rheumatol. 2019 Aug 5:1-4. doi: 10.1080/14397595.2019.1645382. [Epub ahead of print]

PMID:
31314620
11.

Plasma Exchange Therapy to Reduce Mortality in Japanese Patients With Diffuse Alveolar Hemorrhage and Microscopic Polyangiitis.

Abe Y, Yamaji K, Endo Y, Kusaoi M, Nakano S, Yang KS, Tada K, Tsuda H, Tamura N.

Ther Apher Dial. 2019 Jun 24. doi: 10.1111/1744-9987.12939. [Epub ahead of print]

PMID:
31233282
12.

Utility of Multimodality Intravascular Imaging and the Local Hemodynamic Forces to Predict Atherosclerotic Disease Progression.

Bourantas CV, Räber L, Sakellarios A, Ueki Y, Zanchin T, Koskinas KC, Yamaji K, Taniwaki M, Heg D, Radu MD, Papafaklis MI, Kalatzis F, Naka KK, Fotiadis DI, Mathur A, Serruys PW, Michalis LK, Garcia-Garcia HM, Karagiannis A, Windecker S.

JACC Cardiovasc Imaging. 2019 Jun 12. pii: S1936-878X(19)30336-5. doi: 10.1016/j.jcmg.2019.02.026. [Epub ahead of print]

PMID:
31202749
13.

Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan.

Inohara T, Kohsaka S, Yamaji K, Ishii H, Amano T, Uemura S, Kadota K, Kumamaru H, Miyata H, Nakamura M.

BMJ Open. 2019 May 22;9(5):e026683. doi: 10.1136/bmjopen-2018-026683.

14.

Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.

Tambe Y, Terado T, Kim CJ, Mukaisho KI, Yoshida S, Sugihara H, Tanaka H, Chida J, Kido H, Yamaji K, Yamamoto T, Nakano H, Omura S, Inoue H.

Mol Carcinog. 2019 Oct;58(10):1726-1737. doi: 10.1002/mc.23045. Epub 2019 May 20.

PMID:
31106493
15.

EFFECT ON MICROBIAL PRODUCTS ON CAESIUM ELUTION BEHAVIOUR FROM CLAY MINERALS.

Kimura T, Fukutani S, Yamaji K, Ikegami M, Yoneda M.

Radiat Prot Dosimetry. 2019 Oct 1;184(3-4):385-387. doi: 10.1093/rpd/ncz080.

PMID:
31038705
16.

Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions.

Fuku Y, Kadota K, Toyofuku M, Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators.

Am J Cardiol. 2019 Jun 1;123(11):1796-1805. doi: 10.1016/j.amjcard.2019.03.002. Epub 2019 Mar 9.

PMID:
30929770
17.

Oxygen surface exchange properties and surface segregation behavior of nanostructured La0.6Sr0.4Co0.2Fe0.8O3-δ thin film cathodes.

Develos-Bagarinao K, De Vero J, Kishimoto H, Ishiyama T, Yamaji K, Horita T, Yokokawa H.

Phys Chem Chem Phys. 2019 Mar 27;21(13):7183-7195. doi: 10.1039/c9cp00606k.

PMID:
30888381
18.

Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation.

Makiyama A, Chiba A, Noto D, Murayama G, Yamaji K, Tamura N, Miyake S.

Rheumatology (Oxford). 2019 Oct 1;58(10):1861-1869. doi: 10.1093/rheumatology/kez077.

PMID:
30879065
19.

Implications of the local haemodynamic forces on the phenotype of coronary plaques.

Bourantas CV, Zanchin T, Sakellarios A, Karagiannis A, Ramasamy A, Yamaji K, Taniwaki M, Heg D, Moschovitis A, Fotiadis D, Mihalis L, Baumbach A, Torii R, Serruys P, Garcia-Garcia HM, Windecker S, Räber L.

Heart. 2019 Jul;105(14):1078-1086. doi: 10.1136/heartjnl-2018-314086. Epub 2019 Mar 15.

PMID:
30877239
20.

Serum Low-Density Lipoprotein Cholesterol Level After Endovascular Therapy in Patients With Claudication.

Tomoi Y, Yamaji K, Soga Y, Hiramori S, Ando K.

J Endovasc Ther. 2019 Jun;26(3):402-410. doi: 10.1177/1526602819836382. Epub 2019 Mar 15.

PMID:
30873910
21.

Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.

Räber L, Yamaji K, Kelbæk H, Engstrøm T, Baumbach A, Roffi M, von Birgelen C, Taniwaki M, Moschovitis A, Zaugg S, Ostojic M, Pedrazzini G, Karagiannis-Voules DA, Lüscher TF, Kornowski R, Tüller D, Vukcevic V, Heg D, Windecker S.

Eur Heart J. 2019 Jun 21;40(24):1909-1919. doi: 10.1093/eurheartj/ehz074.

PMID:
30851032
22.

In-Hospital Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome With Cardiogenic Shock (from a Japanese Nationwide Registry [J-PCI Registry]).

Kubo S, Yamaji K, Inohara T, Kohsaka S, Tanaka H, Ishii H, Uemura S, Amano T, Nakamura M, Kadota K.

Am J Cardiol. 2019 May 15;123(10):1595-1601. doi: 10.1016/j.amjcard.2019.02.015. Epub 2019 Feb 22.

PMID:
30846213
23.

Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial.

Abe Y, Fujibayashi K, Nishizaki Y, Yanagisawa N, Nojiri S, Nakano S, Tada K, Yamaji K, Tamura N.

Acta Med Okayama. 2019 Feb;73(1):85-89. doi: 10.18926/AMO/56464.

24.

Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.

Adachi M, Kai K, Yamaji K, Ide T, Noshiro H, Kawaguchi A, Aishima S.

Histopathology. 2019 Jul;75(1):63-73. doi: 10.1111/his.13847. Epub 2019 May 16.

PMID:
30811632
25.

Root-endophytic Chaetomium cupreum chemically enhances aluminium tolerance in Miscanthus sinensis via increasing the aluminium detoxicants, chlorogenic acid and oosporein.

Haruma T, Yamaji K, Ogawa K, Masuya H, Sekine Y, Kozai N.

PLoS One. 2019 Feb 22;14(2):e0212644. doi: 10.1371/journal.pone.0212644. eCollection 2019.

26.

Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).

Numasawa Y, Inohara T, Ishii H, Yamaji K, Kohsaka S, Sawano M, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M; J‐PCI Registry Investigators.

J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.

27.

Recurrent cerebral infarctions due to a sewing needle penetrating the left ventricle.

Hirose K, Yamaji K, Sakaguchi G, Okamoto K, Ando K.

Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):838. doi: 10.1093/ehjci/jez007. No abstract available.

PMID:
30715259
28.

Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma.

Yamaji K, Kai K, Komukai S, Koga H, Ide T, Kawaguchi A, Noshiro H, Aishima S.

Hepatobiliary Surg Nutr. 2018 Dec;7(6):443-453. doi: 10.21037/hbsn.2018.10.01.

29.

Influence of Ectomycorrhizal Colonization on Cesium Uptake by Pinus densiflora Seedlings.

Ogo S, Yamanaka T, Akama K, Nagakura J, Yamaji K.

Mycobiology. 2018 Dec 4;46(4):388-395. doi: 10.1080/12298093.2018.1538074. eCollection 2018.

30.

Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.

Räber L, Koskinas KC, Yamaji K, Taniwaki M, Roffi M, Holmvang L, Garcia Garcia HM, Zanchin T, Maldonado R, Moschovitis A, Pedrazzini G, Zaugg S, Dijkstra J, Matter CM, Serruys PW, Lüscher TF, Kelbaek H, Karagiannis A, Radu MD, Windecker S.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1518-1528. doi: 10.1016/j.jcmg.2018.08.024. Epub 2018 Dec 12.

PMID:
30553686
31.

An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.

Numasawa Y, Inohara T, Ishii H, Yamaji K, Hirano K, Kohsaka S, Sawano M, Kuno T, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M; J-PCI Registry Investigators.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):E1-E8. doi: 10.1002/ccd.27986. Epub 2018 Nov 23.

PMID:
30467967
32.

Acute Coronary Syndrome With Unprotected Left Main Coronary Artery Culprit - An Observation From the AOI-LMCA Registry.

Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI-LMCA Stenting Registry Investigators.

Circ J. 2018 Dec 25;83(1):198-208. doi: 10.1253/circj.CJ-18-0896. Epub 2018 Nov 9.

33.

Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.

Obeid S, Frangieh AH, Räber L, Yousif N, Gilhofer T, Yamaji K, Jaguszewski M, Aghlmandi S, Adams J, Bockhorn Y, Templin C, Stähli BE, Jüni P, Rodondi N, Mach F, Roffi M, Windecker S, Maier W, Nietlispach F, Matter CM, Klingenberg R, Lüscher TF.

Cardiol Res Pract. 2018 Sep 25;2018:9762176. doi: 10.1155/2018/9762176. eCollection 2018.

34.

Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.

Yamaji K, Zanchin T, Zanchin C, Stortecky S, Koskinas KC, Hunziker L, Praz F, Blöchlinger S, Moro C, Moschovitis A, Seiler C, Valgimigli M, Billinger M, Pilgrim T, Heg D, Windecker S, Räber L.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006741. doi: 10.1161/CIRCINTERVENTIONS.118.006741.

PMID:
30354590
35.

Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis.

Abe Y, Ando T, Matsushita M, Tada K, Yamaji K, Tamura N.

Rheumatology (Oxford). 2019 Jan 1;58(1):179-181. doi: 10.1093/rheumatology/key310. No abstract available.

PMID:
30351392
36.

Maldevelopment of the submandibular gland in a mouse model of apert syndrome.

Yamaji K, Morita J, Watanabe T, Gunjigake K, Nakatomi M, Shiga M, Ono K, Moriyama K, Kawamoto T.

Dev Dyn. 2018 Nov;247(11):1175-1185. doi: 10.1002/dvdy.24673. Epub 2018 Nov 10.

37.

Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.

Zanchin C, Yamaji K, Rogge C, Lesche D, Zanchin T, Ueki Y, Windecker S, Mohacsi P, Räber L, Sigurdardottir V.

PLoS One. 2018 Aug 27;13(8):e0202950. doi: 10.1371/journal.pone.0202950. eCollection 2018.

38.

Histamine Released From Skin-Infiltrating Basophils but Not Mast Cells Is Crucial for Acquired Tick Resistance in Mice.

Tabakawa Y, Ohta T, Yoshikawa S, Robinson EJ, Yamaji K, Ishiwata K, Kawano Y, Miyake K, Yamanishi Y, Ohtsu H, Adachi T, Watanabe N, Kanuka H, Karasuyama H.

Front Immunol. 2018 Jul 3;9:1540. doi: 10.3389/fimmu.2018.01540. eCollection 2018.

39.

Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progression.

Bourantas CV, Ramasamy A, Karagiannis A, Sakellarios A, Zanchin T, Yamaji K, Ueki Y, Shen X, Fotiadis DI, Michalis LK, Mathur A, Serruys PW, Garcia-Garcia HM, Koskinas K, Torii R, Windecker S, Räber L.

Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):314-322. doi: 10.1093/ehjci/jey091.

PMID:
30020435
40.

Impact of Frailty on Clinical Outcomes in Patients With Critical Limb Ischemia.

Takeji Y, Yamaji K, Tomoi Y, Okazaki J, Tanaka K, Nagae A, Jinnouchi H, Hiramori S, Soga Y, Ando K.

Circ Cardiovasc Interv. 2018 Jul;11(7):e006778. doi: 10.1161/CIRCINTERVENTIONS.118.006778.

PMID:
30006333
41.

COMBO dual-therapy stent: non-inferior to drug-eluting stents or stepping back to bare metal stents?

Yamaji K, Kimura T.

Eur Heart J. 2018 Jul 7;39(26):2469-2471. doi: 10.1093/eurheartj/ehy351. No abstract available.

PMID:
29982320
42.

Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease.

Ando T, Abe Y, Endo Y, Tada K, Yamaji K, Tamura N.

Mod Rheumatol. 2019 Jul;29(4):656-661. doi: 10.1080/14397595.2018.1496873. Epub 2018 Aug 13.

PMID:
29972334
43.

Seasonal Response of North Western Pacific Marine Ecosystems to Deposition of Atmospheric Inorganic Nitrogen Compounds from East Asia.

Taketani F, Aita MN, Yamaji K, Sekiya T, Ikeda K, Sasaoka K, Hashioka T, Honda MC, Matsumoto K, Kanaya Y.

Sci Rep. 2018 Jun 29;8(1):9324. doi: 10.1038/s41598-018-27523-w.

44.

Securely collecting multidimensional health information from patients with rheumatoid arthritis using smart device technology: Beneficial effect for physicians and patients.

Ikeda K, Sekiguchi N, Hirai T, Tanji K, Zushi A, Inoue M, Takasago M, Komatsu T, Morimoto S, Yamaji K, Takamori K, Tamura N, Sekigawa I.

Musculoskeletal Care. 2018 Dec;16(4):494-499. doi: 10.1002/msc.1354. Epub 2018 Jun 28.

PMID:
29956446
45.

The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease.

Matsushita M, Tamura N, Ogasawara M, Tada K, Yamaji K, Takasaki Y.

Arch Rheumatol. 2017 Oct 12;33(1):26-32. doi: 10.5606/ArchRheumatol.2018.6401. eCollection 2018 Mar.

46.

Changes in the Expression of Circulating microRNAs in Systemic Lupus Erythematosus Patient Blood Plasma After Passing Through a Plasma Adsorption Membrane.

Ishibe Y, Kusaoi M, Murayama G, Nemoto T, Kon T, Ogasawara M, Kempe K, Yamaji K, Tamura N.

Ther Apher Dial. 2018 Jun;22(3):278-289. doi: 10.1111/1744-9987.12695. Epub 2018 Jun 6.

PMID:
29873187
47.

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores.

Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort 2, RESET, and NEXT trial investigators.

J Am Heart Assoc. 2018 May 22;7(11). pii: e008708. doi: 10.1161/JAHA.118.008708.

48.

Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers.

Fischer K, Yamaji K, Luescher S, Ueki Y, Jung B, von Tengg-Kobligk H, Windecker S, Friedrich MG, Eberle B, Guensch DP.

J Cardiovasc Magn Reson. 2018 May 7;20(1):31. doi: 10.1186/s12968-018-0446-y.

49.

Prognostic impact of final kissing balloon technique after crossover stenting for the left main coronary artery: from the AOI-LMCA registry.

Nishida K, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Higami H, Yamaji K, Muranishi H, Yamaji Y, Furukawa D, Tada T, Ko E, Kadota K, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators.

Cardiovasc Interv Ther. 2019 Jul;34(3):197-206. doi: 10.1007/s12928-018-0522-0. Epub 2018 Apr 24.

50.

A case of ankylosing spondylitis with concurrent Takayasu arteritis.

Matsushita M, Kobayashi S, Tada K, Hayashi E, Yamaji K, Amano A, Tamura N.

J Int Med Res. 2018 Jun;46(6):2486-2494. doi: 10.1177/0300060518769548. Epub 2018 Apr 24.

Supplemental Content

Loading ...
Support Center